These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6428234)

  • 1. Neurofibromatosis and pregnancy: report of a case complicated by intrauterine growth retardation and oligohydramnios.
    Belton SR; Ferguson JE; Catanzarite VA
    Am J Obstet Gynecol; 1984 Jun; 149(4):468-9. PubMed ID: 6428234
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal renal failure associated with intrauterine growth retardation.
    Steele BT; Paes B; Towell ME; Hunter DJ
    Am J Obstet Gynecol; 1988 Nov; 159(5):1200-2. PubMed ID: 3056007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of furosemide in pregnancies complicated by oligohydramnios.
    Raghavendra BN; Young BK; Greco MA; Lustig-Gillman I; Horii SC; Hirsch MA; Yee J
    Radiology; 1987 Nov; 165(2):455-8. PubMed ID: 3310099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of furosemide to induce diuresis in a growth-retarded fetus.
    Rosenberg ER; Bowie JD
    AJR Am J Roentgenol; 1984 Mar; 142(3):485-6. PubMed ID: 6607630
    [No Abstract]   [Full Text] [Related]  

  • 5. Fetal growth retardation as a complication of pregnancy in patients with neurofibromatosis.
    Blickstein I; Lancet M
    Am J Obstet Gynecol; 1987 Aug; 157(2):343. PubMed ID: 3113250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 in pregnancy.
    Kosec V; Márton I
    Coll Antropol; 2006 Mar; 30(1):247-9. PubMed ID: 16617607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 and pregnancy: maternal complications and attitudes about prenatal diagnosis.
    Cesaretti C; Melloni G; Quagliarini D; Fogliani R; Zaina B; Bedeschi MF; Lalatta F; Trespidi L; Natacci F
    Am J Med Genet A; 2013 Feb; 161A(2):386-8. PubMed ID: 23325535
    [No Abstract]   [Full Text] [Related]  

  • 8. Amniotic fluid erythropoietin and neonatal outcome in pregnancies complicated by intrauterine growth restriction before 34 gestational weeks.
    Seikku L; Rahkonen L; Tikkanen M; Hämäläinen E; Rahkonen P; Andersson S; Teramo K; Paavonen J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Mar; 94(3):288-94. PubMed ID: 25484184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary hypertension in Recklinghausen's disease during pregnancy. A family].
    Bertrand C; Ville Y; Fernandez H
    Presse Med; 1992 Dec 19-26; 21(44):2142-4. PubMed ID: 1297131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between oligohydramnios and intrauterine growth retardation.
    Lin CC; Sheikh Z; Lopata R
    Obstet Gynecol; 1990 Dec; 76(6):1100-4. PubMed ID: 2234721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical artery velocimetry as a predictor of adverse outcome in pregnancies complicated by oligohydramnios.
    Lombardi SJ; Rosemond R; Ball R; Entman SS; Boehm FH
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):338-41. PubMed ID: 2668816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of recognizing oligohydramnios].
    Borthaiser Z; Pál A
    Orv Hetil; 1993 Jan; 134(1):21-3. PubMed ID: 8418444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome.
    Chamberlain PF; Manning FA; Morrison I; Harman CR; Lange IR
    Am J Obstet Gynecol; 1984 Oct; 150(3):245-9. PubMed ID: 6385713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 and masses of the appendix: a case report.
    Rosenberg E; Sheiner E; Holcberg G
    J Reprod Med; 2006 Jul; 51(7):578-80. PubMed ID: 16913550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis and severe hypertension in pregnancy.
    Edwards JN; Fooks M; Davey DA
    Br J Obstet Gynaecol; 1983 Jun; 90(6):528-31. PubMed ID: 6407515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligohydramnios: sonographic diagnosis and clinical implications.
    Hill LM
    Clin Obstet Gynecol; 1997 Jun; 40(2):314-27. PubMed ID: 9199843
    [No Abstract]   [Full Text] [Related]  

  • 17. Oligohydramnios: clinical associations and predictive value for intrauterine growth retardation.
    Philipson EH; Sokol RJ; Williams T
    Am J Obstet Gynecol; 1983 Jun; 146(3):271-8. PubMed ID: 6859136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound evaluation of amniotic fluid: outcome of pregnancies with severe oligohydramnios.
    Bastide A; Manning F; Harman C; Lange I; Morrison I
    Am J Obstet Gynecol; 1986 Apr; 154(4):895-900. PubMed ID: 3515948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical considerations on oligohydramnios].
    Corosu R; Moretti S; Lucchini C; Vizzaccaro F
    Minerva Ginecol; 1999 Jun; 51(6):219-22. PubMed ID: 10479873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of malondialdehyde (MDA) in amniotic fluid and maternal and cord serum in cases of intrauterine growth retardation.
    Bazowska G; Jendryczko A
    Zentralbl Gynakol; 1994; 116(6):329-30. PubMed ID: 8048286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.